Problem With GlaxoSmithKline Depression Drug
British drug giant GlaxoSmithKline(GSK Quote) conceded that its antidepressant Seroxat caused heightened suicidal thinking in some young patients, but urged that nobody stop using it before consulting with a doctor.
The statement follows a recommendation from the U.K. government that physicians stop prescribing the medication to people under 18. "It has become clear that the benefits of Seroxat in children for the treatment of depressive illness do not outweigh these risks," the government said.
GlaxoSmithKline, for whom Seroxat is its second-biggest drug, stressed that the effects were found only in children and adolescents and said there's no good evidence that it causes actual suicides. The drug is called Paxil in the U.S. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,344.84 | 1,095.63 | 2,144.60 | 32.01 |
Oil *
78.55
|
|
UP
34.92
|
UP
4.14
|
UP
6.16
|
DOWN
0.30
|
10 Yr
3.20%
SPDR Gold
115.65
|
|
+0.34%
|
+0.38%
|
+0.29%
|
-0.93%
|
Data delayed 20 minutes |


Connect with TheStreet